Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SOPHIRIS-BIO-120793650/news/Sophiris-Bio-Reports-Administrative-Interim-Analysis-for-the-PLUS-1-Phase-3-Trial-of-PRX302-for-19543937/?utm_source=whatsapp&utm_medium=social&utm_campaign=share